History of cannabis and the endocannabinoid system

Marc-Antoine Crocq, Marc-Antoine Crocq

Abstract

This article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20th century. Cannabis was attested to around 12 000 years ago near the Altai Mountains in Central Asia, and since then, cannabis seeds have accompanied the migration of nomadic peoples. Records of the medicinal use of cannabis appear before the Common Era in China, Egypt, and Greece (Herodotus), and later in the Roman empire (Pliny the Elder, Dioscorides, Galen). In the 19th century, orientalists like Silvestre de Sacy, and Western physicians coming into contact with Muslim and Indian cultures, like O'Shaughnessy and Moreau de Tours, introduced the medicinal use of cannabis into Europe. The structure of the main psychoactive phytocannabinoid, tetrahydrocannabinol (THC), was determined in Israel by Mechoulam and Gaoni in 1964. This discovery opened the gate for many of the subsequent developments in the field of endocannabinoid system (ECS) research. The advances in the scientific knowledge of the ECS place the debate on cannabis liberalization in a new context. .

Keywords: Mechoulam; Moreau de Tours; Silvestre de Sacy; William Brooke O’Shaughnessy; anandamide; cannabis; endocannabinoid; hashish; history; marijuana; tetrahydrocannabinol.

© 2020, AICHServier GroupCopyright © 2020 AICH Servier Group. All rights reserved.

References

    1. Russo EB, Jiang HE, Li X, et al Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot. 2008;59(15):4171–4182.
    1. Pisanti S, Bifulco M. Medical cannabis: a plurimillenial history of an evergreen. J Cell Physiol. 2019;234:8342–8351.
    1. Bonini SA, Premoli M, Tambaro S, et al Review. Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol. 2018;227:300–315.
    1. Clarke RC, Merlin MD. Cannabis. Evolution and Ethnobotany . Berkeley, CA: University of California Press; 2013.
    1. Barbera M. Wanderworten, etymological format: a ‘Hemp’ case study, starting from Votic and Baltofinnic. . Proceedings of the XVII EURALEX International Congress [Internet] . Available at: .
    1. Samorini G. Roma, Italia: Edizioni Studio Tesi; 2016. Mitologia delle piante inebrianti
    1. Quilodrán Jiménez H. Cáñamo Quillotano. Una Herencia Española en Desuso. El Boletín Histórico. Año III No 11 [May 17, 2020]; Available at: .
    1. Scurlock JA, Andersen BR. Chicago, IL: University of Illinois; 2005. Diagnoses in Assyrian and Babylonian Medicine: Ancient Sources, Translations, and Modern Medical Analyses p. 82.
    1. Homer . Loeb Classical Library . Book I. Cambridge, MA: Harvard University Press; 1998. Odyssey; p. 220 sqq.
    1. Homer . New York, NY: Norton and Company; 2018. The Odyssey
    1. Herodotus . Book IV. Paris, France: Les Belles Lettres; 1985. Histories pp. 73–75. Greek text with French translation.
    1. Pliny the Elder [Pline l’Ancien] Books XIX and XX. Paris, France: Les Belles Lettres; 1965, 2003. Histoire Naturelle
    1. Dunn D. New York, NY: Norton and Company; 2019. The shadow of Vesuvius. A life of Pliny
    1. Brunner TF. Marijuana in ancient Greece and Rome? The literary evidence. Bull Hist Med. 1973;47(4):344–355.
    1. Grotenhermen F, Russo E. New York, NY: The Haworth Press; 2002. Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential
    1. Booth M. New York, NY: Thomas Dunne Books; 2015. Cannabis. A History
    1. Silvestre de Sacy AI. Paris, France: Presses Universitaires de France; 2008. La Chrestomatie arabe pp. 448–473. Original edition 1826. New bilingual French-Arabic edition by Académie tunisienne des Sciences, des Lettres et des Arts.
    1. O’Shaughnessy WB. The Journal of the Asiatic Society of Bengal. Calcutta, India: Bishop’s College Press; 1840. Extract from a memoir on the preparations of the Indian hemp, or gunjah (Cannabis Indica), their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases; p. 732 sqq. Vol. VIII. No. 93 September 1839.
    1. Aubert-Roche L. Paris, France: Librairie des sciences médicale de Just Rouvier; 1843. Essai sur le hachisch et son bon emploi dans le traitement de la peste [On hashish and its proper use in the treatment of the plague]
    1. Moreau de Tours J. Paris, France: Fortin, Masson and Cie; 1845. Du hachisch et de l’aliénation mentale [Hashish and insanity]
    1. Fellner S , Unterreiner K. Wien, Austria: Amalthea; 2008. Morphium, Cannabis und Cocain. Medizin und Rezepte im Wien des 19. Jahrhunderts
    1. Reynolds JR. Therapeutical uses and toxic effects of Cannabis Indica. Lancet. 1890;1:637–638.
    1. Baron EP, Lucas P, Eades J, Hogue O. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J Headache Pain. 2018;19(1):37.
    1. Andréasson S, Allebeck A, Engström A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;2(8574):1483–1486.
    1. Weiser M, Noy S. Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci. 2005;7(1):81–85.
    1. Burstein S. Review. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorg Med Chem. 2015;23:1377–1385.
    1. Mechoulam R, Gaoni Y. A total synthesis of dl-Δ1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc. 1965;87:3273–3275.
    1. Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol. 2006;147:S163–S171.
    1. The Scientist . Spain: Fundación Canna; [March 18, 2020]. (video of interview of Mechoulam) Available at: .
    1. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988;34:605–613.
    1. Devane WA, Hanus L, Breuer A, et al Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.
    1. Zou SL, Kumar U. Review. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19(3):833. doi: 10.3390/ijms19030833.
    1. Jarvis S, Rassmussen S, Winters B. Role of the endocannabinoid system and medical cannabis. J Nurse Pract. 2017;13(8):525–531.
    1. Gertsch J, Pertwee RG, Di Marzo V. Phytocannabinoids beyond the Cannabis plant – do they exist? Br J Pharmacol. 2010;160:523–529.
    1. National Academies of Sciences, Engineering, and Medicine 2017 . Washington, DC: The National Academies Press; The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
    1. Hindley G, Beck K, Borgan F, et al Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7:344–353. doi: 10.1016/S2215-0366(20)30074-2.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit